NABsys has secured $10 million in series C preferred stock venture capital financing. The DNA-sequencing company will use the funding to support continued technology development and commercialization. The new investment round was led by Stata Venture Partners. Since April 2009, the firm has raised more than $21 million.

Click here for the release from Business Wire.